While several vaccines have shown efficacy in combination with PD-1 inhibitors, which function by reversing the exhausted T cell phenotype, the combination with PD-1 inhibitors in this study did not enhance the vaccine’s anti-tumor effect. This evidence concerns the gene PDCD1 and neoplasm.